This document discusses post-cholecystectomy syndrome, beginning with case studies of patients who developed symptoms after gallbladder removal surgery. It then defines post-cholecystectomy syndrome as the persistence or development of new symptoms after cholecystectomy. The document outlines that 15% of patients develop symptoms, which can be due to functional disorders, prior surgery complications, or other underlying causes affecting the biliary tract, pancreas, or other organs. Investigation and management depends on identifying the specific cause, which can be found in 95% of cases, through imaging, endoscopy, or surgery to address conditions like sphincter of Oddi dysfunction.
Introduction to post cholecystectomy syndrome, outlining objectives including definition, epidemiology, etiology, pathophysiology, clinical features, investigations, and management.
Presentation of clinical cases highlighting experiences post cholecystectomy, with outcomes linked to underlying conditions like duodenal and caecal carcinoma.
Definition and historical context of post cholecystectomy syndrome, emphasizing persistent symptoms linked to gallbladder removal.
Key epidemiological data showing about 15% develop symptoms post-cholecystectomy, especially those without gallstones.
Explanation of pathophysiological processes leading to symptoms post-surgery, including bile reflux and gastrointestinal issues.
Identification of various causes related to the hepato-biliary system, bile duct, pancreas, and gastrointestinal tract that contribute to post cholecystectomy symptoms.
Overview of common clinical features experienced by patients, including pain, jaundice, diarrhoea, and nausea.
Investigative methods aimed at excluding complications and identifying causes, utilizing serology and imaging techniques.
Management approaches for identifying and treating causes of symptoms, including medication and possible surgical interventions.
Detailed discussion on sphincter of Oddi dysfunction as a complication, including diagnosis and management interventions.
Final remarks and acknowledgment at the conclusion of the presentation.
OUR EXPERIENCE……
MrsDhanuka perera
Later found to have duodenal carcinoma
Mrs Nei Sherine
Expired from caecal carcinoma
Mr H A Jyasena
Has undergone emergency subtotal
cholecystectomy later found to have retained
stones and underwent choledocho-jejunostomy
and currently recovering from surgery.
4.
WHAT IS IT?
First describe in 1947
It is persistence of symptoms following
cholecystectomy
continuation of symptoms which was thought to be
caused by gall bladder
development of new symptoms usually attributed to
gall bladder
symptoms due to absence of gall bladder
5.
EPIDEMIOLOGY
15% ofpatients develop the symptoms
Incidence is high in patients who didn’t have
gallstones
Also high in emergency surgery patients
Pre-operative secure diagnosis reduce
incidence
Functional disorders are the most common
causes
Prior surgery, bile spillage or stone spillage
doesn’t increase the incidence
6.
PATHOPHYSIOLOGY
Due toincrease bile flow in to upper GI tract
bile reflux gastritis and esophagitis
Due to bile in the lower GI tract
diarrhoea and lower abdominal pain
Other symptoms could be resulting from
structures in biliary tree or extra biliary
structures
7.
AETIOLOGY
Hepato-biliary system
Cystic duct and gall bladder remnant
Residual or reformed gall bladder
Stump cholelithasis
Neuroma
Liver
Fatty liver, sclerosing cholangitis, cirrhosis
INVESTIGATIONS
Aim isto exclude complication of
cholecystectomy and identify other causes
Serology
FBC
LFT
Amylase
Imaging
chest x ray, abdominal x ray,
barium swallow and follow through
USS, MRCP
MANAGEMENT
If causeis identifiable manage specifically
Patients with IBS – bulking agents, anti
spasmodics sedatives
Antacids and H2 receptor blockers
Surgery for operable diseases
If no obvious cause is identifiable
ERCP
Open surgery
16.
OPEN SURGERY
Exlap
Look for another cause
Intra op cholangiogram
Dissect neuroma and scar tissue around cystic
duct
If pancreatic head is normal can do
sphincteroplasty
If pancreatic head has chronic pancreatitis
proceed with choledocho duodenostomy
17.
SPHINCTER OF ODDIDYSFUNCTION
Complex muscular structure
Surrounds distal CBD, pancreatic duct, ampulla
of Vater
Caused by structural or functional abnormalities
Fibrosis of sphincter from gallstone migration,
operative or endoscopic trauma, pancreatitis or
nonspecific inflammatory processes
Sphincter dyskinesia or spasm
~1% of patient undergoing cholecystectomy
18.
Labs: ↑amylase, LFT
ERCP: delayed emptying of contrast medium
from CBD
↑ basal sphincter pressure >40mmHg
US: dilated CBD
19.
MANAGEMENT
High-dose Cachannel blockers or nitrates,
but evidence not convincing
Sphincterotomy (endoscopic or
transduodenal)
Mucosa-mucosa apposition in surgical
approach can minimize scarring and
restenosis
60-80% successful if have documented
objective evidence